Christina M. Ackermann

Overview 2021 2020 2019 2018 2017 2016

2021

In 2021, Christina M. Ackermann earned a total compensation of $4.6M as Executive Vice President, General Counsel and Head of Commercial Operations at Valeant Pharmaceuticals International, a 29% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan	$862,000
Option Awards	$600,033
Salary	$750,000
Stock Awards	$2,348,225
Other	$14,330
Total	$4,574,588

Ackermann received $2.3M in stock awards, accounting for 51% of the total pay in 2021.

Ackermann also received $862K in non-equity incentive plan, $600K in option awards, $750K in salary and $14.3K in other compensation.

Rankings

In 2021, Christina M. Ackermann's compensation ranked 2,890th out of 12,415 executives tracked by ExecPay. In other words, Ackermann earned more than 76.7% of executives.

Classification	Ranking	Percentile
All	2,890 out of 12,415	77th
Division Manufacturing	1,150 out of 5,505	79th
Major group Chemicals And Allied Products	456 out of 2,375	81st
Industry group Drugs	400 out of 2,096	81st
Industry Pharmaceutical Preparations	268 out of 1,546	83rd

Pay ratio

Christina M. Ackermann's Pay	$4,574,588
Median Employee's Pay	$44,617
Pay Ratio	103 to 1

In 2021, the annual total compensation of Christina M. Ackermann was $4,574,588.

The annual total compensation of the median employee at Valeant Pharmaceuticals International was $44,617.

The ratio of Christina M. Ackermann's pay to the pay of median employee was therefore 103 to one.

Source: SEC filing on May 2, 2022.

Overview 2020

Ackermann's colleagues

We found five more compensation records of executives who worked with Christina M. Ackermann at Valeant Pharmaceuticals International in 2021.